Despite its potential, cancer metabolomics faces several challenges. The complexity and dynamic nature of the metabolome make it difficult to capture a complete and accurate profile. Moreover, metabolic changes can be influenced by numerous factors, including diet, microbiota, and co-existing medical conditions, which can confound the results. Standardizing sample collection, processing, and data analysis methods is also critical for reproducibility and comparison across studies.
